This past Monday, the World Health Organization (WHO) released its Global tuberculosis (TB) report for 2017. The report documents a roller-coaster of successes and failures in the effort to combat TB. While 53 million lives have been saved since 2000, the disease remains the world’s leading infectious killer. Director-General, Dr. Tedros calls for a different approach, one that parallels action … Read More
By: Dr. Lucica Ditiu and Dr. Catharina Boehme The numbers speak for themselves. In 2015 alone: 1.8 million died from tuberculosis (TB); 10.4 million people fell ill with the disease; and An estimated 480,000 developed multidrug resistant-TB (MDR-TB). All of this, combined with the airborne transmission of the disease, makes TB the leading infectious disease killer (surpassing both HIV … Read More
The Board of the Global Fund meets twice a year on average. At each meeting the Board takes a number of decisions, which are legally binding on the Board, the Secretariat, and in-country partners.
Globally, there is growing recognition that the fight against TB must actively seek the participation of those most affected by the disease – individuals who have had TB and their families. It is their stories, their experiences, their voices that matter, that will resonate with communities, policymakers and governments and that can reduce stigma, accelerate investment in TB, advocate for … Read More
Today, March 24th, is World TB Day. World TB Day commemorates the day that Dr. Robert Koch announced his startling discovery of the cause of tuberculosis (TB). The discovery was a breakthrough and brought new hope to sufferers. More than 130 years on, it remains the world’s leading infectious killer. 1.8 million people worldwide died from the disease in 2015, … Read More
Each year on March 24th, we celebrate World TB Day. Although tuberculosis (TB) is preventable and curable, it remains one of the top ten causes of death in the world.
The 2016 conference theme is “Confronting Resistance: Fundamentals to Innovations”, which encompasses a number of critical areas for discussion ranging from the growing problem of resistance to existing TB drugs to the challenge presented by the powerful tobacco industry’s resistance to efforts to control tobacco use. Most broadly, the theme is also the next natural step after 2015’s “New Agenda” – … Read More
by Ian Matthews, Director, GBCHealth With the release in May of the final report and recommendations of the Review on Antimicrobial Resistance, GBCHealth has convened a group of global leaders to discuss the potential impact of AMR and their priorities for immediate action. The interview series, which will be published over the next three weeks, is intended to supplement the … Read More
Last week, the Global Fund to Fight AIDS, Tuberculosis and Malaria hosted its Fifth Replenishment Conference where government and private sector partners pledged a total of $12.9 billion for 2017-2019. This replenishment was particularly noteworthy for its inaugural commitments – such as a $10 million pledge from the Government of Qatar – and pledges from African countries and companies. Kenya and South Africa pledged … Read More
In honor of World TB Day and World Malaria Day, we are highlighting some of the extraordinary work the PSD member companies are undertaking in the fight to end these epidemics. Read more about how Eli Lilly is bringing global attention to the TB-diabetes co-epidemic, Janssen’s partnership to expand access to a new MDR-TB drug, Sumitomo Chemical’s commitment to protect … Read More